Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Mitragynine

Mitragynine in Austria: not individually verified

Not individually verified

We have not confirmed that Mitragynine specifically is scheduled in Austria, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record
Not confirmed. The status of manufactured mitragynine could not be conclusively settled, and the obstacle is the reach of a derivative definition rather than a missing document. An indole ethylamine substructure is present, which makes Annex II group 6 a plausible route, since that group covers tryptamine and compounds derivable from it including those bearing the permitted substituents. Group 2 was also reviewed. But mitragynine's bridged polycyclic extensions require a defensible legal application of the derivative language, and no conclusive Austrian interpretation was obtained. The narcotics instrument holds no mitragynine entry and no demonstrated extension from a named parent, and the psychotrope instrument holds none. NPSG §1(3) makes natural plant material and synthetically manufactured alkaloid different things, so the leaf's answer does not carry across. No prescription listing was located, the medicines act's functional and presentation criteria need product facts rather than deciding a generic structural fit, and the novel food and food safety provisions address commercial marketing without producing an NPS outcome. The public chemistry record fixes formula and connectivity and supplies no Austrian legal interpretation.

Confirm directly with Austria’s national drug authority or your own embassy before you rely on anything.

What Austria HAS confirmed for related substances

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.